Concepedia

Stergios Moschos

SM

Statistics

Publications

11

Citations

959

H-Index

11

Active since

2006

Affiliations

University of Pittsburgh(Current)

UPMC Hillman Cancer Center

Stergios Moschos is an author at University of Pittsburgh specializing in oncology, cancer immunology, and cancer immunotherapy.

Publications per year

2006–2017

11

Publications

11

Neoadjuvant Treatment of Regional Stage IIIB Melanoma With High-Dose Interferon Alfa-2b Induces Objective Tumor Regression in Association With Modulation of Tumor Infiltrating Host Cellular Immune Responses

Stergios Moschos, Howard Edington, Stephanie R. Land et al. · Journal of Clinical Oncology · 2006 · 244 citations · Full text

Medicine, Immunology, Oncology +17

Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma

Ahmad A. Tarhini, John Cherian, Stergios Moschos et al. · Journal of Clinical Oncology · 2011 · 148 citations · Full text

Medicine, Immunology, Oncology +17

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

Jennifer Schlegel, Maria J. Sambade, Susan Sather et al. · Journal of Clinical Investigation · 2013 · 144 citations · Full text

Medicine, Cancer Biology, Oncology +17

Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696

John M. Kirkwood, Stergios Moschos, Mark R. Albertini et al. · Clinical Cancer Research · 2009 · 139 citations · Full text

Medicine, Immunology, Oncology +17

SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas

Stergios Moschos, Amanda Smith, Maja Mandić et al. · Oncogene · 2007 · 85 citations

Medicine, Molecular Biology, Oncology +17

1–5 of 11